Prodigious Therapeutic Effects of Combining Mesenchymal Stem Cells with Magnetic Nanoparticles

Overview

Journal World J Stem Cells

Publisher Baishideng Publishing Group

Date 2022 Sep 26

PMID 36157526

Authors

Ejlal Abu-El-Rub

Ramada R Khasawneh

Fatimah Almahasneh

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSCs) have gained wide-ranging reputation in the medical research community due to their promising regenerative abilities. MSCs can be isolated from various resources mostly bone marrow, Adipose tissues and Umbilical cord. Huge advances have been achieved in comprehending the possible mechanisms underlying the therapeutic functions of MSCs. Despite the proven role of MSCs in repairing and healing of many disease modalities, many hurdles hinder the transferring of these cells in the clinical settings. Among the most reported problems encountering MSCs therapy are loss of tracking signal post-transplantation, insufficient migration, homing and engraftment post-infusion, and undesirable differentiation at the site of injury. Magnetic nano particles (MNPs) have been used widely for various biomedical applications. MNPs have a metallic core stabilized by an outer coating material and their ma gnetic properties can be modulated by an external magnetic field. These magnetic properties of MNPs were found to enhance the quality of diagnostic imaging procedures and can be used to create a carrying system for targeted delivery of therapeutic substances mainly drug, genes and stem cells. Several studies highlighted the advantageous outcomes of combining MSCs with MNPs in potentiating their tracking, monitoring, homing, engraftment and differentiation. In this review, we will discuss the role of MNPs in promoting the therapeutic profile of MSCs which may improve the success rate of MSCs transplantation and solve many challenges that delay their clinical applicability.

References

Sharma R, Pollock K, Hubel A, McKenna D . Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014; 54(5):1418-37. PMC: 6364749. DOI: 10.1111/trf.12421. View

Song N, Scholtemeijer M, Shah K . Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Trends Pharmacol Sci. 2020; 41(9):653-664. PMC: 7751844. DOI: 10.1016/j.tips.2020.06.009. View

Di Maggio N, Martella E, Meikle S, Columbaro M, Lucarelli E, Santin M . Rapid and efficient magnetization of mesenchymal stem cells by dendrimer-functionalized magnetic nanoparticles. Nanomedicine (Lond). 2016; 11(12):1519-34. DOI: 10.2217/nnm-2016-0085. View

Ahn Y, Kong T, Choi J, Yun W, Key J, Seo Y . Strategies to enhance efficacy of SPION-labeled stem cell homing by magnetic attraction: a systemic review with meta-analysis. Int J Nanomedicine. 2019; 14:4849-4866. PMC: 6613362. DOI: 10.2147/IJN.S204910. View

Zhang H, Li S, Liu Y, Yu Y, Lin S, Wang Q . FeO@GO magnetic nanocomposites protect mesenchymal stem cells and promote osteogenic differentiation of rat bone marrow mesenchymal stem cells. Biomater Sci. 2020; 8(21):5984-5993. DOI: 10.1039/d0bm00906g. View

Huang J, Wang D, Chen J, Liu W, Duan L, You W . Osteogenic differentiation of bone marrow mesenchymal stem cells by magnetic nanoparticle composite scaffolds under a pulsed electromagnetic field. Saudi Pharm J. 2017; 25(4):575-579. PMC: 5447436. DOI: 10.1016/j.jsps.2017.04.026. View

Maulik G, Shrikhande A, Kijima T, Ma P, Morrison P, Salgia R . Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 2001; 13(1):41-59. DOI: 10.1016/s1359-6101(01)00029-6. View

Ali A, Shah T, Ullah R, Zhou P, Guo M, Ovais M . Review on Recent Progress in Magnetic Nanoparticles: Synthesis, Characterization, and Diverse Applications. Front Chem. 2021; 9:629054. PMC: 8314212. DOI: 10.3389/fchem.2021.629054. View

Ngen E, Artemov D . Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives. Int J Mol Sci. 2017; 18(1). PMC: 5297829. DOI: 10.3390/ijms18010198. View

10.

Silva L, da Silva J, Ferreira G, Silva R, Lima E, Azevedo R . Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications. J Nanobiotechnology. 2016; 14(1):59. PMC: 4949766. DOI: 10.1186/s12951-016-0213-x. View

11.

Du V, Luciani N, Richard S, Mary G, Gay C, Mazuel F . A 3D magnetic tissue stretcher for remote mechanical control of embryonic stem cell differentiation. Nat Commun. 2017; 8(1):400. PMC: 5596024. DOI: 10.1038/s41467-017-00543-2. View

12.

Singh D, McMillan J, Liu X, Vishwasrao H, Kabanov A, Sokolsky-Papkov M . Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues. Nanomedicine (Lond). 2014; 9(3):469-85. PMC: 4338921. DOI: 10.2217/nnm.14.4. View

13.

Ullah I, Subbarao R, Rho G . Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015; 35(2). PMC: 4413017. DOI: 10.1042/BSR20150025. View

14.

Thu M, Bryant L, Coppola T, Jordan E, Budde M, Lewis B . Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med. 2012; 18(3):463-7. PMC: 3296876. DOI: 10.1038/nm.2666. View

15.

Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta J . Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010; 5(6):933-46. PMC: 3017479. DOI: 10.2217/rme.10.72. View

16.

Dabrowska S, Del Fattore A, Karnas E, Frontczak-Baniewicz M, Kozlowska H, Muraca M . Imaging of extracellular vesicles derived from human bone marrow mesenchymal stem cells using fluorescent and magnetic labels. Int J Nanomedicine. 2018; 13:1653-1664. PMC: 5865569. DOI: 10.2147/IJN.S159404. View

17.

Yang H, Hua M, Liu H, Huang C, Wei K . Potential of magnetic nanoparticles for targeted drug delivery. Nanotechnol Sci Appl. 2013; 5:73-86. PMC: 3781723. DOI: 10.2147/NSA.S35506. View

18.

Mahmoudi M, Sant S, Wang B, Laurent S, Sen T . Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2010; 63(1-2):24-46. DOI: 10.1016/j.addr.2010.05.006. View

19.

Labusca L, Herea D, Minuti A, Stavila C, Danceanu C, Plamadeala P . Magnetic Nanoparticles and Magnetic Field Exposure Enhances Chondrogenesis of Human Adipose Derived Mesenchymal Stem Cells But Not of Wharton Jelly Mesenchymal Stem Cells. Front Bioeng Biotechnol. 2021; 9:737132. PMC: 8558412. DOI: 10.3389/fbioe.2021.737132. View

20.

Unterweger H, Janko C, Schwarz M, Dezsi L, Urbanics R, Matuszak J . Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. Int J Nanomedicine. 2017; 12:5223-5238. PMC: 5533574. DOI: 10.2147/IJN.S138108. View